Euronews is no longer accessible on Internet Explorer. This browser is not updated by Microsoft and does not support the last technical evolutions. We encourage you to use another browser, such as Edge, Safari, Google Chrome or Mozilla Firefox.
BREAKING NEWS

Lonza snaps up Novartis fill-and-finish facility to expand offering

Lonza snaps up Novartis fill-and-finish facility to expand offering
FILE PHOTO: The logo of Swiss pharmaceutical group Lonza is seen at its headquarters in Basel, Switzerland March 26, 2019. REUTERS/Arnd Wiegmann -
Copyright
ARND WIEGMANN(Reuters)
Euronews logo
Text size Aa Aa

ZURICH (Reuters) – Lonza Group <LONN.S> is buying a sterile fill-and-finish facility from Novartis <NOVN.S> as the Swiss drug ingredients maker boosts its offering for pharmaceuticals companies.

“The new manufacturing facility in Stein will be our first sterile drug product fill and finish facility and will work in close synergy with our existing facility in the Stuecki Park in Basel,” Lonza said in a statement that gave no financial terms for the transaction.

(Reporting by John Miller; Editing by Michael Shields)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.